The company is still called Cytocore and still trades under the same symbol. The regulators would not allow them to do a reverse split prior to getting into the Medite deal. From a business standpoint it is a much stronger company; however I just don't believe they are going to change their stance on allowing them to do a reverse splint.
News 
Market Data 
Discover 
